A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
Neuropathy, or nerve dysfunction ... adding in an OTC pain med was the perfect pain management trio for me,” she said. Riesebeck was a fan of the Peach flavor she tested: “The flavor was ...
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...
While New Orleans prepares for the excitement of the big game, it’s important to remember that sports injuries aren’t limited to the professionals. High school athletes, weekend warriors, and generall ...
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
“When you talk about a pinched nerve in the neck, that’s usually going to bring on symptoms in the neck and sometimes the ...
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...
Explore how chemotherapy causes peripheral neuropathy in 40% of cancer patients. Learn about the risk factors and the need ...
The study involved 150 people who received nerve injections to test prolonged pain. A novel biomarker signature that assessed cortical activity predicted individual pain sensitivity, the PREDICT ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results